Treatment effects of once-weekly dulaglutide versus insulin glargine in patients with different baseline glycemic patterns (based on high/low fasting or high/low postprandial glucose): a post hoc analysis of the AWARD-2 clinical trial
Georgino, Francesco, Yu, Maria, Haupt, Axel, Milicevic, Zvonko, Garcia-Perez, Luis-Emilio, and Rasalam, Roy (2018) Treatment effects of once-weekly dulaglutide versus insulin glargine in patients with different baseline glycemic patterns (based on high/low fasting or high/low postprandial glucose): a post hoc analysis of the AWARD-2 clinical trial. In: [Presented at the Australian Diabetes Society Annual Scientific Meeting]. From: Australian Diabetes Society Annual Scientific Meeting, 22-24 August 2018, Adelaide, SA, Australia.
|
PDF (Poster)
- Presentation
Download (5MB) | Preview |
Abstract
The effects of DU 1.5 mg and Glar were compared in patients with T2D at 52 weeks from the AWARD-2 study with prevalent elevations in fasting glucose (FG), postprandial glucose (PPG), or both FG and PPG at baseline. Changes in glycated hemoglobin (A1c), FG, PPG, body weight, and hypoglycemia were investigated.
| Item ID: | 58095 |
|---|---|
| Item Type: | Conference Item (Poster) |
| Keywords: | diabetes management; dulaglutide; glargine |
| Related URLs: | |
| Date Deposited: | 22 Apr 2019 23:47 |
| FoR Codes: | 11 MEDICAL AND HEALTH SCIENCES > 1103 Clinical Sciences > 110306 Endocrinology @ 100% |
| SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920104 Diabetes @ 100% |
| Downloads: |
Total: 56 Last 12 Months: 6 |
| More Statistics |
Actions (Repository Staff Only)
 |
Item Control Page |